top of page
Search

Breast Biopsy Market Segmentation: Regional Insights, Top Players, Size, Share, and Trends Shaping the Future 2025-2032

  • Writer: Ashish Jagtap
    Ashish Jagtap
  • Jan 6
  • 3 min read

Straits Research, a leading market research firm, is pleased to announce the latest insights and trends in the global breast biopsy market. The market was valued at USD 2.3 billion in 2023 and is expected to grow at a robust Compound Annual Growth Rate (CAGR) of 10.8%, reaching USD 5.8 billion by 2032. The forecast period for this market growth spans from 2025 to 2032, highlighting a substantial increase in demand for breast biopsy solutions worldwide.

Market Definition

A breast biopsy is a medical procedure used to remove tissue or fluid from the breast for diagnostic purposes. This procedure is commonly employed to determine the presence of cancerous cells, monitor changes in tissue, and plan treatment strategies. With an increasing prevalence of breast cancer and heightened awareness around early diagnosis, the demand for breast biopsy solutions has significantly surged. This surge is expected to continue with technological advancements in biopsy techniques and growing healthcare investments in early cancer detection.

Market Dynamics

The breast biopsy market is driven by several key factors and trends, which are shaping its growth:

Key Trends:

  1. Advancements in Image-Guided Biopsy: The growing popularity of image-guided biopsy methods, such as ultrasound-guided and MRI-guided biopsies, is revolutionizing the market. These methods improve the accuracy and precision of breast tissue sampling.

  2. Increasing Popularity of Liquid Biopsies: Liquid biopsy, a non-invasive method that uses blood samples to detect cancer-related biomarkers, is gaining traction as a promising alternative to traditional biopsies.

Market Drivers:

  1. Rising Incidence of Breast Cancer: The global increase in breast cancer cases, particularly in developed regions, has driven the demand for early and accurate diagnostic techniques, directly contributing to the growth of the breast biopsy market.

  2. Technological Innovations in Biopsy Techniques: Continuous innovation in biopsy needles, forceps, and guidance systems has led to more efficient, safer, and patient-friendly procedures, bolstering the market.

Market Opportunities:

  1. Growth in Emerging Markets: The Asia Pacific region, with its rapidly expanding healthcare infrastructure and increasing awareness of cancer screening, represents a significant growth opportunity for the breast biopsy market.

  2. Rising Demand for Personalized Medicine: The shift toward personalized medicine, which involves tailoring treatments based on genetic information, creates demand for advanced biopsy techniques that enable precise diagnosis and therapy selection.

Market Segmentation

The global breast biopsy market is categorized as follows:

  • By Product

    • Biopsy Needles

    • Biopsy Forceps

    • Guidance Systems

    • Needle-Based Biopsy Guns

    • Localization Wires

    • Other Guidance Techniques

  • By Biopsy Type

    • Fine-Needle Aspiration Biopsy (FNAB)

    • Core Needle Biopsy (CNB)

    • Vacuum-Assisted Breast Biopsy (VABB)

    • Excisional and Incisional Breast Biopsy

    • Open Surgical Breast Biopsy

    • Liquid Breast Biopsy

  • By Guidance

    • Image-Guided Biopsy

    • Liquid Biopsy

  • By Application

    • Early Cancer Screening

    • Therapy Selection

    • Treatment Monitoring

    • Recurrence Monitoring

  • By End-User

    • Hospitals and Surgical Centers

    • Breast Care Centers

    • Imaging and Diagnostic Centers

For detailed segmentation information, please visit: https://straitsresearch.com/report/breast-biopsy-market/segmentation

Key Players in the Breast Biopsy Market

The breast biopsy market features several prominent players, including:

  • Hologic, Inc.

  • Danaher Corporation

  • Becton, Dickinson, and Company

  • QIAGEN

  • Illumina, Inc.

  • Merit Medical Systems

  • Medtronic

  • Bio-Rad Laboratories, Inc.

  • F. Hoffmann-La Roche Ltd

  • Thermo Fisher Scientific, Inc.

Regional Insights

  • Dominated Region: North America remains the dominant market for breast biopsy procedures, driven by high awareness levels, advanced healthcare infrastructure, and a high rate of early cancer screenings.

  • Fastest Growing Region: The Asia Pacific region is expected to witness the fastest growth in the breast biopsy market, with an increasing adoption of advanced healthcare technologies, government initiatives for cancer awareness, and a rising number of breast cancer cases in countries such as China and India.

For more information or to make inquiries, please visit: https://straitsresearch.com/buy-now/breast-biopsy-market

About Straits Research

Straits Research is a leading global market research and consulting firm. We offer in-depth, accurate, and actionable market insights across a wide range of industries. Our mission is to help clients make informed, data-driven decisions and achieve sustainable growth in today’s ever-evolving business environment.

 
 
 

Kommentare

bottom of page